This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Centre de Regulació Genòmica | |
|---|---|
| Name | Centre de Regulació Genòmica |
| Native name | Centre de Regulació Genòmica |
| Established | 2000 |
| Type | Research institute |
| Director | Ruedi Aebersold |
| City | Barcelona |
| Country | Spain |
| Campus | Barcelona Biomedical Research Park |
Centre de Regulació Genòmica is a biomedical and genomic research institute based in Barcelona, Spain, focused on molecular regulation, systems biology, and computational genomics. Founded at the turn of the 21st century, the institute integrates experimental platforms in molecular biology, proteomics, single-cell genomics, and bioinformatics to address problems in human disease, developmental biology, and evolutionary genomics. The centre engages with universities, hospitals, research councils, and technology companies to translate basic research into clinical and biotechnological applications.
The institute was established in 2000 amid an expansion of biomedical infrastructure in Catalonia involving the Barcelona Biomedical Research Park, the Universitat Pompeu Fabra, and the Hospital del Mar. Early leadership included figures linked to the European Molecular Biology Laboratory and collaborations with the European Research Council and the Wellcome Trust. Throughout the 2000s it expanded capacities in genomics, influenced by milestones such as the Human Genome Project and the rise of next-generation sequencing technologies. The centre’s growth paralleled regional initiatives like the Catalan Government research investments and the development of the PRBB campus. Notable visits and cooperative agreements involved delegations from the European Commission, the National Institutes of Health, and the Max Planck Society.
Research programs encompass regulatory genomics, systems biology, proteomics, single-cell biology, spatial transcriptomics, and computational biology, aligning with methodologies pioneered at institutions like the Broad Institute, EMBL and the Sanger Institute. Projects address gene regulation, chromatin biology, signal transduction, and genetic variation informed by standards from the ENCODE Project and the 1000 Genomes Project. The centre runs interdisciplinary teams comparable to labs at Massachusetts Institute of Technology, Harvard University, Stanford University, and University of Cambridge, applying tools from CRISPR editing, mass spectrometry proteomics, and RNA-seq analysis. Collaborative consortia have linked the centre with clinical partners including Vall d'Hebron University Hospital, Hospital Clínic de Barcelona, and international centres such as the Karolinska Institutet and Institut Pasteur.
Laboratory infrastructure includes high-throughput sequencing platforms similar to those from Illumina and Oxford Nanopore Technologies, proteomics suites compatible with instruments from Thermo Fisher Scientific, and microscopy cores akin to facilities at the European Molecular Biology Laboratory and the Max Planck Institute for Molecular Cell Biology and Genetics. Computational infrastructure integrates high-performance computing clusters, cloud resources provided by vendors like Amazon Web Services and Google Cloud Platform, and bioinformatics pipelines informed by frameworks from Bioconductor and Galaxy (project). The institute occupies laboratory and office space within the Barcelona Biomedical Research Park and maintains biobanks and core facilities comparable to those at the Wellcome Sanger Institute.
The centre hosts doctoral students and postdoctoral fellows in joint programs with Universitat Pompeu Fabra, University of Barcelona, and international universities such as University College London and ETH Zurich. Educational activities include workshops on computational genomics, training courses modeled after EMBL-Europe programs, and summer schools resembling those organized by the Cold Spring Harbor Laboratory. Outreach initiatives collaborate with cultural institutions like the CosmoCaixa and engage with policy forums including the European Commission science-policy platforms. The centre contributes to public science communication alongside media partners and participates in citizen science efforts inspired by projects at the Wellcome Trust.
Formal collaborations link the institute to national bodies such as the Spanish National Research Council and regional entities like the Catalan Agency for Management of University and Research Grants. International partnerships include consortia with the Broad Institute, European Molecular Biology Laboratory, Institut Pasteur, Karolinska Institutet, and industry partners in biotechnology and pharmaceuticals such as Novartis, Bayer, and Roche. The centre participates in EU-funded networks under frameworks like Horizon 2020 and maintains ties with philanthropic funders exemplified by the Gates Foundation and the Wellcome Trust.
Governance combines academic oversight with advisory boards featuring scientists affiliated with institutions such as ETH Zurich, University of Cambridge, and Harvard Medical School. Funding streams include competitive grants from the European Research Council, national grants from the Spanish Ministry of Science and Innovation, regional support via the Agència de Gestió d'Ajuts Universitaris i de Recerca, philanthropic awards, and contracts with industry partners. Administrative structures follow models used at the Max Planck Society and prominent European research institutes.
Scientific outputs include publications in journals like Nature, Science, Cell, and Nature Genetics on topics ranging from chromatin structure to single-cell atlases. The centre’s researchers have received recognition through awards such as grants from the European Research Council, fellowships from the Human Frontiers Science Program, and prizes analogous to honours awarded by the EMBO and the Royal Society. Contributions to large-scale projects have linked the centre to datasets integrated within initiatives like the Human Cell Atlas and the ENCODE Project.